Dr. Anne De Groot will be a Keynote Speaker at the SMI’s inaugural conference on Immunogenicity, taking place in London on July 14th and 15th.

The SMi Conference brochure and agenda can be found here.

Here is some information about Dr. De Groot’s Keynote Presentation on  July 14th at 11:00 am:

Tregitopes an Immunomodulation Powerhouse:
Regulating Immune Responses to Biologics
• Modulation of T cell responses in the context of protein therapy
and inflammation may contribute to the design of improved
biologic therapeutics for a wide range of clinical conditions.
• A critical flaw in most predictions of immunogenicity is the
failure to factor regulatory T cell epitopes (Tregitopes) into the
• The presenter will provide several case studies that validate the
critical importance of Tregitopes to biologics, including but not
limited to protein replacement therapies, blood factor
replacement therapies, monoclonal antibodies as well as
mitigation of auto-inflammatory and autoimmune responses

If you would like to meet Dr. De Groot for a partnering meeting or outside the conference to learn more about our technology please do not hesitate to contact us.

More info about Tregitope here.

EpiVax at SMi in London